Gastroenterology & Hepatology Patient Care
A doctor in a patient room

Quality Care Across Communities

Cutting-edge therapeutics for all forms of digestive and liver diseases at clinics throughout Michigan

We provide the highest quality of care and offer the most cutting-edge therapeutics available. Our faculty are also leaders in their respective areas of research, conducting and participating in many pharmaceutical clinical investigations. The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis and treatment of gastrointestinal diseases.

The Department of Gastroenterology & Hepatology physicians, along with GI radiologists, surgeons, physician assistants, nurse practitioners, nurses and dietitians, provide care for all forms of digestive and liver diseases at numerous clinics in Ann Arbor, surrounding communities and the state of Michigan. In addition, we have several specialty, multidisciplinary programs including the Comprehensive Pancreas Program, Esophageal Disorders Program, Functional Bowel Disorders Program, Hepatology Program, IBD Program, Interventional Endoscopy Program and Michigan Bowel Control Program.
Find a Doctor

Find a doctor who meets your needs

Find a Clinic

Find a clinic near you

Patient & Visitor Guide

Find additional information and resources for patient and visitors

For Referring Providers

Connect with M-LINE for referral and consultation information

Individualized Care
Gastrointestinal Care at U-M Health

We are home to one of the largest digestive health and liver disease programs in the country. Our highly-trained specialists are dedicated to innovative and effective treatments for every single patient. Find the treatment that's right for you.

Gastroenterology Services
Featured News & Stories See all news 27th Annual Liver Disease Wrap-Up
Department News
27th Annual Liver Disease Wrap-Up
Join us for the 27th Annual Liver Disease Wrap-Up conference taking place on Saturday, December 7, 2024
 machine beige black
Health Lab
Histotripsy liver tumor trial successful, early clinical adoption recommended
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.
 stethoscope listening to phone with doctor projected out of it
Health Lab
Could your phone detect hepatic encephalopathy by listening to you read?
Research suggests that one day a phone app could be able to detect the development of hepatic encephalopathy in patients just by listening to them speak.
 bacteria blue yellow
Health Lab
New guideline for Helicobacter pylori includes change to primary treatment recommendation
The American Journal of Gastroenterology has published a new guideline on the treatment of Helicobacter pylori (H. pylori) Infection. 
 Photo portrait of Ryan Stidham, MD
Department News
Appointment of Ryan Stidham, M.D., M.S., as DCMB Associate Chair for Clinical and Translational Research and as Associate Director of the Center for Computational Medicine and Bioinformatics (CCMB)
Ryan Stidham, MD, MS, from the Department of Internal Medicine, is appointed as DCMB Associate Chair for Clinical and Translational Research and as Associate Director of the Center for Computational Medicine and Bioinformatics (CCMB)
 hands holding syringe white
Health Lab
How do GLP-1 weight loss drugs affect the liver?
Glucagon-like peptide-1, or GLP-1, receptor agonists, that aid in weight loss, are now being investigated for their ability to help other patients, including those with liver disease. However, a research letter discusses the first known case of hepatitis and jaundice in a patient taking these drugs.